Blue Jay Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $6.68M | Buy |
+145,303
| New | +$6.68M | 4.55% | 14 |
|
|
2016
Q4 | – | Sell |
-226,501
| Closed | -$11.5M | – | 20 |
|
|
2016
Q3 | $11.5M | Sell |
226,501
-79,129
| -26% | -$4.01M | 6.26% | 9 |
|
|
2016
Q2 | $13.9M | Sell |
305,630
-50,880
| -14% | -$2.31M | 9.12% | 1 |
|
|
2016
Q1 | $14.1M | Buy |
356,510
+156,450
| +78% | +$6.19M | 9.02% | 3 |
|
|
2015
Q4 | $11.3M | Buy |
+200,060
| New | +$11.3M | 3.81% | 15 |
|